Purchase Order 36C25019P0587
- Not listed
- This federal contract award is for the provision of clinical analyzers and reagents to the U.S. Department of Veterans Affairs (VA). The prime contractor, Sebia, Inc., is a global leader in automated electrophoresis technologies and has been awarded a $161,164.36 firm fixed-price delivery order contract to supply these products and services. The contract has no set-aside designation and is part of a larger $32 million Federal Supply Schedule contract with the VA, effective through March 2026,...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Sebia, Inc., a global leader in automated electrophoresis technologies. The $204,725.00 firm fixed-price delivery order contract provides Sebia's SEBIA ELECTROPHESIS CAPILLARYS, reagents, and consumables to support clinical laboratory operations at VA medical facilities. The award is part of Sebia's larger $32 million Federal Supply Schedule contract to supply critical laboratory analyzers, reagents, and...
- This firm fixed-price delivery order was awarded to Sebia, Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration for the provision of SEBIA reagents. The contract has a potential value of $201,968.70 and a completion date of March 31, 2023. It is not set aside and is issued under the Critical Analyzers, Laboratory (FSS-66-III) federal supply schedule contract. Sebia, Inc. is a global leader in automated electrophoresis and has a strong track record of securing prime...
- The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order contract to Sebia, Inc., a provider of automated electrophoresis technologies and clinical laboratory services. The $78,069.32 contract, which has no set-aside designation, is for the delivery of Sebia reagents, supplies, and consumables to support laboratory testing at the Michael E. DeBakey VA Medical Center in Houston, Texas. The one-year base period of performance runs from December 1, 2023 through November 30,...
- This is a firm fixed-price purchase order for electrophoresis reagents awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sebia, Inc., a global leader in automated electrophoresis testing equipment and services. The $152,927.83 contract provides electrophoresis analyzers, reagents, consumables, and testing services to support clinical laboratory programs at VA medical facilities. Sebia has held several Indefinite Delivery Indefinite Quantity (IDIQ) and Federal...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Sebia, Inc., a global leader in automated electrophoresis technologies. The $104,197.40 Blanket Purchase Agreement (BPA) call contract is for the provision of testing materials, specifically for critical laboratory analyzers, reagents, controls, consumables, and services related to electrophoresis technologies. The contract is not set-aside and is part of a larger $32 million Federal Supply Schedule contract with...
- This is a federal contract award to Sebia, Inc., a global leader in automated electrophoresis technologies, to provide clinical analyzers and reagents to the U.S. Department of Veterans Affairs (VA). The $213,024.34 firm fixed price delivery order contract has an ultimate completion date of September 30, 2026 and is not set aside. Sebia, Inc. has established itself as a critical provider of specialized clinical laboratory technologies that support protein analysis, diagnostic testing, and...
- This is a $19,212 firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs to Sebia, Inc., a global leader in automated electrophoresis technologies. The contract, which does not have a set-aside designation, is for the provision of electrophoresis-related products and services, including clinical analyzers, reagents, consumables, testing services, equipment maintenance, and installation. Sebia, Inc. holds...
- The Department of Veterans Affairs (VA), through Veterans Integrated Service Network 17, awarded a $59,323.19 firm fixed-price purchase order to Sebia, Inc. for reagents and supplies on December 1, 2024. The contract, which carries an ultimate completion date of January 9, 2026, will be performed in Houston, Texas. This award was made without a set-aside designation, reflecting Sebia's competitive position in the federal healthcare marketplace. As a global leader in automated electrophoresis...
- This federal contract award is for the provision of an electrophoresis analyzer and reagents to the Veterans Integrated Service Network 8 (VISN 8), a unit of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Sebia, Inc., a global leader in automated electrophoresis, for a firm fixed price of $45,813.60. The contract has a period of performance through March 13, 2024. Sebia, Inc. has a strong track record of securing prime federal contracts to provide specialized medical...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order contract to Sebia, Inc., a global leader in automated electrophoresis technologies, for REAGENT RENTAL SERUM. The $328,108.60 contract supports the provision of electrophoresis analyzers, reagents, consumables, testing services, and maintenance across VA medical facilities. Sebia has held several significant federal contract vehicles with the VA, including a $32 million Federal Supply Schedule contract and a $4.23 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract, which have facilitated the company's support for clinical laboratory and diagnostic testing programs within the VA healthcare system. This contract, which has an ultimate completion date of February 29, 2024, is not set aside for any particular business type.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00007 | Supplemental Agreement for work within scope | ($15k) | 10/15/24 | |
| P00006 | Exercise an Option | $68.7k | 2/16/23 | |
| P00004 | Exercise an Option | $68.7k | 2/11/22 | |
| P00003 | Exercise an Option | $68.7k | 2/18/21 | |
| P00002 | Funding Only Action | ($405) | 7/23/20 |